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Abstract The postmortem diagnosis of early myocardial in-
farction is a challenge for forensic pathologists because the
routine histology is neither specific. Many authors have sug-
gested the use of the immunohistochemistry to fill the gaps in
the histological diagnosis of early myocardial infarction. This
review aims to analyse advances of immunohistochemical de-
tection of early cardiac damage due to ischaemia. To this pur-
pose, we reviewed experimental studies that investigated im-
munohistochemical markers and their estimated timing of ex-
pression. The review was performed according to specific in-
clusion and exclusion criteria, and a total of 23 studies assessing
the immunohistochemical markers for the diagnosis and timing
of early myocardial infarction were identified. The literature
review highlights that the analysed markers are complement
components, others being inflammatory mediators, cardiac cell
proteins, plasma proteins, stress or hypoxia-induced factors and
proteins associated with heart failure. All studies demonstrate
the effectiveness of the tested markers in the early detection of
myocardial infarction in both animal and human samples.
Keywords Early myocardial infarction .
Immunohistochemistry . Sudden cardiac death . Systematic
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Introduction
Sudden cardiac death (SCD) represents an unexpected natural
death from a cardiac cause that occurs within a short period of
time, generally within the first hour from the onset of symp-
toms, in a subject without any prior condition that would ap-
pear fatal [1]. The annual incidence of SCD in Europe and
North America is below 50–100/100,000 persons [2–5]. In
Asia, the reported value is 40/100,000 persons [6].
The most common cause of sudden cardiac death is coro-
nary atherosclerotic disease (CHD), followed by cardiomyop-
athies, myocarditis, valvular disease and channelopathies.
Generally, the accepted proportion of all SCDs resulting from
CHD is ≈80 %, and SCD accounts for ≈50 % of all CHD-
related deaths. Considering these data, during the past years,
many studies explaining the mechanism of SCD due to CHD
were carried out. Knowledge about the pathophysiology of
SCD, which can be differentiate into vascular pathophysiolo-
gy, myocardial pathophysiology and systemic modulations,
have allowed understanding the causes of CHD-related
SCDs in relation to different factors such as the severity, dis-
tribution and characteristics of the anatomic substrate of cor-
onary atherosclerotic and myocardial tissue alterations.
Therefore, in the cases of SCDs following coronary athero-
sclerotic disease, the cause of death can be a transient or acute
myocardial ischaemia, an arrhythmia due to myocardial scar
and remodelling, and a sudden cardiac arrest due to an ar-
rhythmia followed by acute or subacute changes in coronary
plaque and/or transient coronary artery spasm [7]. Therefore,
understanding the pathophysiology of CHD-related SCD is
critical in postmortem diagnosis.
In some cases, the postmortem diagnosis of sudden cardiac
death due to myocardial ischaemia is a major concern in fo-
rensic autopsy cases. This represents a challenge for forensic
pathologists when death occurs within minutes to a few hours
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after an ischaemic insult. In fact, myocardial cell death does
not occur instantaneously at the onset of ischaemia, and, at
least, several hours are required before the myocardial necrosis
can be identified with standard macroscopic or microscopic
examination. Recognition of early myocardial damage using
routine haematoxylin and eosin (H&E) staining is neither spe-
cific nor sensitive enough if the death of the patient occurred
shortly (<6 h) after the onset of the ischaemic injury [8].
In this regard, the usefulness of histochemical (i.e.
chromotrope aniline blue) and immunohistochemical
methods for the diagnosis of early myocardial damage
following ischaemia has been suggested. In particular,
many studies have been carried out about markers to
use with immunohistochemistry in the diagnosis of early
myocardial infarction. In fact, before the influx of in-
flammatory molecules and cells become histologically
detectable, the presence of cellular and humoral media-
tors can be evaluated by immunohistochemistry, and
many studies demonstrate that this method may be an
excellent tool for the postmortem diagnosis and timing
of cardiac damage induced by ischaemia.
In light of the several evidences about the usefulness of
immunohistochemistry, this review aims to analyse advances
of immunohistochemical detection of early cardiac damage
due to ischaemia. For this purpose, we reviewed experimental
studies that investigated immunohistochemical markers and
their estimated timing of expression.
Methods
This systematic review has been conducted employing the
PubMed database. On this website, we searched for articles
between 1990 and September 2016 using the key terms
Bimmunohistochemistry^ AND Bearly myocardial infarction^.
We decided to use as a rule of thumb the fact that the ab-
stracts of those articles that indicated in the title that they might
have evaluated the use of immunohistochemical markers for
the diagnosis and timing of early myocardial ischaemia were
to be read. The entire article was read if the abstract indicated
that the article potentially met the inclusion criteria.
Articles were included in the following review according to
the following inclusion criteria: English language, year of
publication from 1990 and positive results within 6 h from
the onset of ischaemic damage.
Articles were excluded by title, abstract or full text for
irrelevance to the topic in question. Further exclusion criteria
were article reviews and editorial comments. Furthermore, we
decided to start our research from 1990 considering that the
most relevant studies were published after this date.
Data derived from our research of articles include authors,
publication dates, type of samples, type of markers, their ex-
pression and timing.
Results
In Fig. 1, the flow of articles retrieved for the review is report-
ed. As summarised in Table 1, a total of 27 studies assessing
the immunohistochemical markers for the diagnosis and
timing of early myocardial infarction were identified.
According to Table 1, Casscells et al. studied the
expression of fibronectin in a sample of rats killed after
left coronary ligation at different time points. The study
showed an increase in the intensity of staining at 4 h
after coronary artery ligation in the cytoplasm, Z bands
and interstitial space of some myocytes located in the
area supplied by the ligated vessels. Moreover, fibronec-
tin staining in the cytoplasm and matrix of capillary,
venous and arterial endothelial cells of the infarct centre
and border zone was found. At 24 h, similar patterns
about fibronectin localization were observed, but there
was an increase in the intensity of staining [9].
Brinkmann et al. studied various immunohistochemical
markers in a human sample of cardiac deaths with or without
coronary thrombosis, which were subdivided on the basis of
histological evidences of infarction or not. The studied
markers were: desmin, myoglobin, fibrinogen and C5b-9
complement complex. Particularly, the authors highlighted
that desmin and myoglobin reacted very much in parallel,
even if the myoglobin indicated a higher degree of sensitivity.
The immunohistochemical staining in the ischaemic fibres
showed the depletion of desmin, the negative reaction for
Records identified through database 
searching 
(n = 404) 
Sc
re
en
in
g 
In
clu
de
d 
El
ig
ib
ili
ty
 
Id
en
ﬁ
ca
o
n 
Records  with studies before 
1990 were removed 
(n = 390) 
Records excluded based 
on title or language 
(n = 262)
Full-text articles assessed 
for eligibility 
(n = 54) 
Full-text articles excluded, 
with reasons 
(n = 27) 
Studies included in 
systematic review 
(n = 27)   
Abstracts screened 
(n = 128) 
Abstracts excluded with 
reasons 
(n = 74) 
Fig. 1 Flowchart of the results of literature search
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Table 1 Studies evaluating the
immunohistochemical markers
for early myocardial infarction
diagnosis and timing
Authors Year Sample Marker Range of
expression
Manner of
expression
Casscells et al. [9] 1990 Animals Fibronectin ≥4 h +
Brinkmann et al. [10] 1993 Human C5b-9 NHS +
Desmin −
Myoglobin −
Fibrinogen +
Thomsen et al. [11] 1994 Human C5b-9 0–170 h +
Väkevä et al. [12] 1994 Animals C1, C3, C8, C9 ≥3 h +
CD59 ≥6 h −
Zhang et al. [13] 1996 Human Desmin ≥1 h −
α-Actinin
Vinculin
Hu et al. [14] 1996 Human Fibronectin NHS +
Hansen et al. [15] 1999 Human Troponin I NHS −
Ortmann et al. [16] 2000 Human FABP NHS −
Troponin CT −
Desmin–myoglobin −
Fibrinogen–fibronectin +
C5b-9 +
Robert-Offerman
et al. [17]
2000 Human C9 NHS +
Piercecchi-Marti et al.
[18]
2001 Human C9 NHS +
Xiaohong et al. [19] 2002 Animals Fibrinogen >30 min +
Myoglobin −
Fishbein et al. [20] 2003 Animals CT-T, CT-I >30 min −
Panpìn et al. [21] 2006 Human HIF-1α ≈2 h +
Meng et al. [22] 2006 Animals H-FABP 15 min–4 h −
Human NSH
Willam et al. [23] 2006 Animals HIF-1 6–24 h +
PHD2, PHD3 −
Jasra et al. [24] 2012 Human CT-I <6 h −
C9 +
Hashmi et al. [25] 2013 Animals Dystrophin ≥20 min +
Kakimoto et al. [26] 2013 Human SORBS2 <7 h −
Bi et al. [27] 2013 Animals S100A1 ≥15 min −
Human <6 h-NHS
Kawamoto et al. [28] 2014 Human npCX-43 NHS +
CX-43 −
Mayer et al. [29] 2014 Human Dityrosine ≥4 +
Al-Salam et al. [30] 2014 Animals GAL-1 20 >min < 60 +
Turillazzi et al. [31] 2014 Human IL-15, MCP-1 ≤4–6 h +
Hashmi et al. [32] 2015 Animals GAL-3 ≥30 min +
Jia et al. [33] 2015 Animals CTnI 0.50–1 h +
>1 h −
Human HS −
Shabaiek et al. [34] 2016 Human H-FABP NHS −
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the myoglobin, the extensive positive reaction for fibrinogen
and a slight positive reaction for C5b-9 [10].
Thomsen et al. conducted a study on C5b-9 complex in
cardiac autopsy material. This study showed intense and spe-
cific immunohistochemical staining in the cases with limited
possibility of histological diagnosis of myocardial ischaemia,
particularly in subjects with an average survival time of 7–
10 h post-infarction [11].
On the basis of the knowledge about the complement acti-
vation following the occurrence of ischaemia, Väkevä et al.
studied the expression of C1, C3, C8 and C9 in a sample of
rats killed at different time points after left coronary ligation.
Immunostaining at 2 h showed foci of C3 deposition in the
myocardial areas supplied by the ligated vessels, whilst the
positivity of the other complement components was found at
3 h, where haematoxylin and eosin staining pointed out the
earliest signs of myocardial infarction [12].
Zhang et al. analysed the expression of three cytoskeletal
proteins—desmin, α-actinin and vinculin—in a sample of au-
topsy cases with sudden death. The immunohistochemistry
showed the myocardial extensive loss of the proteins in the
subject who died after 1 h from the onset of the symptoms;
moreover, larger cellular depletion was observed for α-actinin
and vinculin [13].
Hu et al. conducted a study on fibronectin expression in
human autopsy material of subjects who died from definite or
suspected myocardial infarction. In the suspected myocardial
infarction group without microscopic evidences of ischaemic
injuries, immuno-analysis showed positive staining for fibro-
nectin in the cytoplasm of myocytes which was distributed in
individual myocytes or group of myocytes, or in confluent
areas, or segmentally in ischaemic myocytes [14].
Hansen et al. carried out a study on autopsy heart about
the expression of cardiac troponin I. Significant reduction
or total loss of staining was observed in the cases with
definite infarcted areas, as well as in the groups of possi-
ble macroscopic signs of acute infarction with or without
microscopic findings [15].
Ortmann et al. conducted a comparative study on the anal-
ysis of the depletion of the cardiac antigens FABP, troponin C
and T, desmin and myoglobin, loss of CD59 and deposition of
the plasma antigens fibrinogen, fibronectin and the comple-
ment complex C5b-9. These markers were tested in autopsy
samples of subjects who died from acute myocardial infarc-
tion and acute cardiac death. The study confirmed the useful-
ness of C5b-9 as a marker of early myocardial ischaemia and
highlighted that the depletion of cardiac antigens started ear-
lier than the deposition of plasma antigens [16].
Another study regarding the complement C9 compo-
nent was conducted by Robert-Offerman et al. in a hu-
man sample. The authors pointed out the positive stain-
ing only in some cases without definite histological
signs of myocardial infarction and concluded that C9
immunostaining clearly pointed towards myocardial in-
farction in 47 % of cases, where routine histological
evaluation was not conclusive [17].
Xiaohong et al. carried out an experimental study on the
expression of fibrinogen and myoglobin in a sample of rats
killed at different time points after left coronary ligation.
Immunostaining showed local and incomplete depletion of
myoglobin and light fibrinogen positivity in the 30-min group.
These patterns gradually intensified with the prolongation of
ischaemia (at 1, 2 and 3 h), and the staining extended from the
subendocardium cells to the middle myocardium and
subepicardial cells [18].
The same marker was studied by Piercecchi-Marti
et al., who tested C9 in a human cardiac sample with
histological signs of myocardial infarction and without
or not obvious histological signs. The cases with non-
obvious signs presented a well-documented history of
myocardial ischaemia of less than 10 h old and severe
or moderate atherosclerotic damage; the cases without his-
tological signs presented severe atherosclerotic coronary
disease and a survival estimated range of 1–3 h. The im-
munohistochemical study revealed intense cytoplasmic
and sometimes membranous immunostaining in the group
with myocardial ischaemia of less than 10 h, but no sen-
sitive and no specific immunostaining in the subject
where the death occurred within 1 h from the onset of
the symptoms [19].
Table 1 (continued)
Authors Year Sample Marker Range of
expression
Manner of
expression
Sabatasso et al. [35] 2016 Animals Troponin CT ≤1 h −
Myoglobin −
Fibronectin +
C5b-9 ≤2 h +
npCX-43 ≤30 min +
Jun B +
+: positive staining; −: loss of staining
NHS: without histological signs (assumed time, ≤6 h); HS: with histological signs (assumed time, >6 h)
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Fishbein et al. analysed the loss of cardiac troponins Tand I
in an experimental study conducted on animals that underwent
permanent coronary occlusion for 0.5–6 h, or occlusion of
0.75–6 h followed by reperfusion, and with or without histo-
logical signs of myocardial necrosis. The study revealed that
loss of both cardiac troponins T and I could be detected in the
necrotic myocardium of animals with permanent occlusion. In
these cases, cardiac troponin loss was greater at the periphery
than at the centre of the lesions; moreover, loss of cardiac
troponin T appeared earlier and greater than loss of cardiac
troponin I. The same results are observed in the animals with
occlusion followed by reperfusion and histologic evidences of
myocardial necrosis. The authors highlighted that immunohis-
tochemical staining for cardiac troponins T and I may be more
sensitive than routine haematoxylin–eosin staining for the rec-
ognition of myocardial ischaemia over 30 min [20].
Pampìn et al. evaluated the immunohistochemical expres-
sion of hypoxia-inducible factor (HIF-1α) in cases of sudden
cardiac death with suggestive circumstance of antemortem
myocardial ischaemia, but neither microscopic evidence.
The study showed positivity to antibody in about 79 % and
particularly revealed myocyte nuclear staining followed by
mixed nuclear and cytoplasmic staining. The authors observed
nuclear positivity in the subpopulation with duration of previ-
ous symptoms ≤2 h and mixed staining in the subpopulation
with duration of previous symptoms >2 h [21].
Meng et al. studied the heart-type fatty acid binding protein
(H-FABP), performing an immunohistochemical study on an
animal sample and forensic autopsy sample. The animal sam-
ple was represented by rats, with acute myocardial infarction
produced by left anterior descending coronary ligation and
killed at various ischaemia intervals. This study showed full
depletion of H-FABP involving almost all myocardium in the
group of rats killed after 4 h from coronary ligation and patchy
depletion in the 2- and 1-h groups. In the autopsy sample, the
authors showed extensive or focal loss of H-FABP in the
group of subjects who died from suspected early myocardial
infarction, where death occurred within 6 h from the onset of
the symptoms [22].
Willam et al. analysed the expression of HIF-1α in relation
to the expression of prolyl hydroxylase PHD2 and PHD3 that
regulate the HIF activity. The study was conducted on a sam-
ple of rats subjected to ligation of the left anterior descending
coronary artery and then killed after different postoperative
intervals. The authors showed marked positivity of HIF close
to the infarcted area and for PHD evaluated a minor patchy
peri-infarct staining for PHD2 and a lesser staining for PHD3,
at the 6-h and 1-day time points [23].
Jasra et al. tested the expression of cardiac troponin I (CT-I)
and complement C9 component in a sample of autopsy cases
with no histological signs of infarction (<6 h) and with micro-
scopically visible signs with traditional H&E staining. The
immunohistochemical analysis of all the cases <6 h
highlighted negative to weakly positive staining for CT-I,
demonstrating loss of cardiac antigen; more than 85 % of
these cases showed a weakly positive staining or a few isolat-
ed cells staining for C9 [24].
Another study conducted by Hashmi et al. was on the ex-
pression of dystrophin in a sample of mice killed after induc-
tion of myocardial infarction at different time points. The im-
munohistochemistry of the 20- to 30-min post-infarction sam-
ples showed well-demarcated foci of complete sarcolemmal
loss of dystrophin staining in the region supplied by ligated
artery and areas of partial loss of membranous staining in
vicinity to those [25].
Kakimoto et al. analysed the expression of sorbin and SH3
domain-containing protein 2 (SORBS2), an adapter protein
that functions in cytoskeletal organization, cell adhesion and
signalling pathways. The sample was represented by autopsy
cardiac material of patients who died within 7 h from the onset
of the symptoms in which there were histological signs of
contraction band or wavy fibres or irregular patterns such as
fragmented myocytes. The study showed different patterns in
relation to the histological evidences: in contraction bands was
observed a blurry immunostaining; in wavy fibres was ob-
served the negative staining of somemyocytes and the weakly
staining of the adjacent myocardial cytoplasm; in irregular
fibres, the immunostaining signals clearly disappeared from
the Z lines. Thus, the immunohistochemistry showed the early
loss of SORBS2 in infarcted heart tissues [26].
Bi et al. performed a study on the downregulation of
S100A1, a dimeric Ca2+-binding protein, in a sample of rats
with induced myocardial ischaemia and in a sample of human
myocardial tissue obtained from autopsies. In the animal sam-
ple, the authors highlighted the depletion of S100A1 in a few
cardiomyocytes as low as 15 min after artery occlusion; after
4 h, the immunohistochemical staining showed well-
demarcated areas of complete depletion of cytoplasmic stain-
ing. In the human sample without microscopic evidences of
myocardial infarction, there were cases that showed massive
depletion of S100A1 expression and cases with patchy deple-
tion or sparse loss in a few myocytes [27].
Kawamoto et al. evaluated the expression of connexin43
(Cx43), non-phosphorylated Cx43 (np-Cx43) and zonula
occludens-1 (ZO-1). Cx43 is an important gap junction pro-
tein in human cardiomyocytes localized at the intercalated
discs in which stimuli such as ischaemia induce non-
phosphorylation (np-Cx43) and redistribution to the cyto-
plasm and/or lateral cell border of myocytes; ZO-1 is a tight
junction protein playing a role in anchoring Cx43 to the cyto-
skeleton. On the basis of this knowledge, the immunohisto-
chemical study was conducted on a sample of human hearts
obtained from autopsies. Particularly, the analysis showed
positive distribution of Cx43 and np-Cx43 in intercalated
discs, cytoplasm and lateral cell border; the positive distribu-
tion of ZO-1 was in the cytoplasm. The most important
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findings resulted from np-Cx43 that was detected more fre-
quently and intensely in the cytoplasm of the cardiac tissues of
subjects who died from sudden cardiac death without apparent
myocardial necrosis [28].
Mayer et al. performed a study to evaluate the expres-
sion of dityrosine as a protein product of oxidative stress
to use in the diagnosis of early myocardial infarction. The
study was conducted on a sample of autopsy heart of a
human subject who died following myocardial infarction,
then subdivided on the basis of the histological age. The
authors showed intracellular space positivity in some
cases with estimated survival times of 0–4 h and in most
cases belonged to the group with survival times of 4–24 h.
Positive staining was evaluated also in some cases of the
control group in which the subjects died after a presum-
ably shorter agony. Moreover, the authors compared these
results with fibronectin and C5b-9 and assumed that
dityrosine appears also quite early after an ischaemic
event [29].
Al-Salam et al. tested the expression of galectin-1
(GAL-1) as hypoxia-induced protein of early myocardial
infarction. The authors carried out a study on a mice sam-
ple with induced myocardial ischaemia at different time
points, between 20 min and 24 h. The increased expres-
sion of GAL-1 was very well demarcated in all tested time
points; moreover, there was evidence of an increase of
demarcated areas of no or low expression in relation to
the increase in ischaemia time, which means that as time
proceeds, dying cells stop the expression of GAL-1 [30].
Turillazzi et al. performed an immunohistochemical study
on some inflammatory mediators: CD15, IL-1β, IL-6,
TNF-α, IL-15, IL-8, MCP-1, CD18 and tryptase. The study
evaluated the expression of these mediators in an autopsy
sample of subjects who died following myocardial infarction
with survival times ranging from 4–6 h tomore than 12 h from
the onset of the symptoms. The most important results were
observed for MCP-1 (monocyte chemotactic protein 1) and
IL-15; in fact, immunostaining showed intense positivity of
both markers in the very early phase between 0 and 4 h and
their gradual reduction after 6 h [31].
Hashmi et al. studied the expression of galectin-3
(GAL-3), involved in mitosis, proliferation of cells and
anti-apoptotic mechanism. The study was conducted on
a sample of mice where the myocardial infarction was
induced by left anterior descending coronary artery liga-
tion; then, the animals were killed at different time points.
The immunohistochemistry highlighted both cardiac
myocyte and endothelial cell staining at 30–60 min and
4 h. A very characteristic pattern was evaluated in the 24-
h post-myocardial infarction group; in fact, there was a
high expression of GAL-3 in the area supplied by ligated
artery, surrounding an area of very low or no expression
of GAL-3. The area showing no expression of GAL-3 was
the area of the infarct and consisting of dead myocytes,
whilst the surviving cardiomyocytes and endothelial cells
surrounding the infarct were the ones showing very high
staining [32].
Jia et al. tested the expression of cardiac troponin inhibitor
(CTnI), the inhibitor subunit that forms part of the regulatory
troponin complex. The expression of CTnI was evaluated in
samples of rabbits and human myocardium. In the animal
study, the authors found increased cytoplasmic immunostain-
ing for CTnI in 0.5 h of ligation, and after 1 h, the well-defined
corresponding infarcted areas began to show a clear reduction
in CTnI expression; so, as the ligation time increased, the
immunoreactivity was reduced, and complete depletion was
observed after 8 h of ligation. The immunohistochemical
marker was also tested in the myocardial tissues of subjects
who died from acute myocardial infarction demonstrating the
partial or diffuse depletion of CTnI expression in the infarcted
areas [33].
Shabaiek et al. [34] tested again H-FABP in autopsy hearts.
The immunohistochemical study showed cytoplasmic stain-
ing by various degrees, ranging from minimal depletion and
up to near-total depletion, in the group of hearts with probable
signs of ischaemia and coronary stenosis.
Sabatasso et al. carried out an experimental study on the
expression of troponins I and T, myoglobin, fibronectin, C5b-
9, non-phosphorylated Cx43 (np-Cx43), JunB and cyto-
chrome C. The study was performed on a sample of rats killed
after induction of myocardial ischaemia at different time
points. The authors reported the most important immunohis-
tochemical results on the earliest expressions of np-Cx43 and
JunB, in which immunopositivity was observed in the interval
15–30 min after coronary ligation. np-Cx43 positivity was in
the gap junction, whilst JunB showed a nuclear positivity. A
larger and more intense staining was observed, proportionally,
with increasing durations of ischaemia. The other markers’
expressions were observed in the interval 1–2 h [35].
Discussion
Acute myocardial infarction (AMI) is a common cause of
sudden unexpected death and often follows severe coronary
artery occlusion [36]. The clinical diagnosis of AMI can be
easy using electrocardiography, biochemical markers and im-
aging [37].
Postmortem diagnosis is generally based on macroscopic
evidences of myocardial necrosis and on routine histology
findings. Haematoxylin and eosin staining is a useful tool in
cases where polymorphonuclear leucocyte infiltration and cell
death can be demonstrated. These findings begin to be detect-
able after 6–8 h from the onset of ischaemic injury, so the early
diagnosis of myocardial infarction is a challenge for the fo-
rensic pathologist when it occurs before this period. This is
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because several hours elapse for cells death, over the first 6 to
24 h [38, 39]. The earliest (before 6 h) histological signs de-
scribed are mild myofiber eosinophilia, elongation of sarco-
meres and nuclei, wavy fibres, interstitial oedema and contrac-
tion band, but these cannot be considered pathognomonic of
myocardial infarction [40–44].
Many authors have suggested the use of immunohisto-
chemistry to fill the gaps in the histological diagnosis of early
myocardial infarction. In view of this, the current knowledge
about the chronology of the myocardial tissue responses to the
occurrence of ischaemia has an important role [45–47].
Fundamental are the knowledge about the innate immune re-
sponse, the consequent inflammatory reaction, and the cellular
and extracellular alterations. Thus, the immunohistochemical
detection of immune-inflammatory and cellular phenomena
accompanying the cardiac alterations during the early inflam-
matory phase of myocardial ischaemia could be an excellent
diagnostic tool.
In this regard, the presented review summarises and anal-
yses the studies about the immunohistochemical markers test-
ed between 1990 and September 2016.
The most studied marker for the forensic diagnosis of
early myocardial infarction is the membrane attack com-
plex C5b-9. The C5b-9 complex is the terminal product
of the complement system activation. MAC interacts
and damages the plasma membrane, causing direct cell
lysis [48]. The first studies about the C5b-9 complex
demonstrated the immunohistochemical detection of the
marker in the myocardial infarction areas, so it was
judged to be specific for necrosis [49, 50]. Then, this
antigen was detected in myocardial ischaemic tissues in
the cases that do not show histological signs and/or
after 30–40 min from the beginning of the ischaemic
injuries [9, 10, 14]. On the basis of the experimental
results, pathologists agree to consider it useful to visu-
alize early ischaemic myocardial damage.
The literature review highlights that the other analysed
markers are complement components and others are inflam-
matory mediators, cardiac cell proteins and plasma proteins.
The role of the activation of the complement system has
been documented in both experimental and clinical studies of
myocardial infarction [51–53]. Complement activation can
occur through three pathways that begin with the fragmenta-
tion of the C3 component, to which follows the activation of
C5 and the formation of the membrane attach complex C5b-9.
The immunohistochemical studies were conducted for the di-
agnosis of early myocardial infarction on the complement
components with regard to C1, C3, C8 and C9. All markers
are tested in animal samples demonstrating an early immune
positivity already 3 h after the occlusion of the coronary [12].
C9 components were also studied in human samples showing
clearly positive immunostaining in half of the myocardial in-
farction cases within approximately 6 h [17]. Moreover,
another study assesses the specificity and sensitivity of C9
expression as 85 % (62.11–96.79 % confidence interval) in
the cases without histological evidences of myocardial infarc-
tion and survival times between 3 and 10 h [18].
Knowledge of the chronology of the responses of the myo-
cardial tissue to the ischaemic injury, and particularly about
the early inflammatory phase, has suggested the possibility to
test some inflammatory mediators [54, 55]. The usefulness of
these mediators is documented by one study that reports the
immunohistochemical evaluation of CD15, IL-1β, IL-6,
TNF-α, IL-15, IL-8, MCP-1, CD18 and tryptase. Whilst
CD15, IL-1β, IL-6, TNF-α, IL-8, CD18 and tryptase show a
larger immune reaction gradation over 6 h, IL-15 and MCP-1
reveal intense immunostaining very early, earlier than 4 h [31].
Several studies on the cardiac cell proteins concern: myo-
globin, cardiac troponins I and T (CT-I and CT-T, respective-
ly), heart-type fatty acid binding protein (H-FABP) and cyto-
skeletal proteins.
About myoglobin and cardiac troponins, the early loss of
proteins detectable within 6 h from the onset of the symptoms
is clearly documented in all immunohistochemical studies on
human samples [10, 15, 16, 24]. These evidences are also
associated with the results obtained from animal studies in
which the loss of cardiac troponins and myoglobin appeared
earlier [19, 35]; moreover, it was observed that the loss of
troponin T appeared earlier and is greater than the loss of
cardiac troponin I [20]. Moreover, there is a study on the
expression of cardiac troponin inhibitor (CTnI), the inhibitor
subunit that forms part of the regulatory troponin complex,
which shows a clear reduction in CTnI expression from 1 h
after the induced myocardial ischaemia [33].
H-FABP is an abundant protein in the cytoplasm of myo-
cardial cells that set in the uptake and oxygenation of long-
chain fatty acids. It has been demonstrated that H-FABP is
more sensitive and specific than myoglobin for clinical detec-
tion of myocardial infarction within 12 h after the onset of the
symptoms by quantifying its plasma concentration [56, 57].
The sarcolemmal damage due to ischaemia determines the
cellular leaks of H-FABP and its passage in blood vessels.
Thus, the immunohistochemical studies about H-FABP ex-
pression in myocardial infarcted tissues highlight the partial
depletion of the marker after 15 min and the full loss after 4 h
in experimental animal models [22]. The usefulness of the
immunohistochemical detection of H-FABP is also demon-
strated in human samples where the myocardial infarction
was suspected and no or nonspecific histological signs were
present [16, 22, 34].
The sarcolemmal damage following myocardial ischaemia
is expressed by the cytoskeletal damage, and this could lead to
cellular loss of the cytoskeletal proteins. The immunohisto-
chemical studies reviewed the cytoskeletal alterations follow-
ing early myocardial infarction with regard to desmin, vincu-
lin and α-actinin [10, 13, 16]. These studies confirm the
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depletion of cellular staining of all markers particularly detect-
able after 1 h from the onset of the symptoms. Also, compar-
ing the three markers, desmin decrements later than vinculin
andα-actinin. Moreover, a study about dystrophin, a cytoskel-
etal protein that forms a complex with glycoproteins involved
in contractile force transmission and stabilization of the plas-
ma membrane, has been reviewed [58, 59]. As well as for
other proteins, the immunohistochemical study on a mice
sample shows loss of dystrophin staining in ischaemic
myocytes [25]. The dystrophin loss is detectable from
20 min after induced ischaemia, and it appears as areas of
complete sarcolemmal loss and areas of partial sarcolemmal
loss.
In the group of myocardial cell proteins tested as immuno-
histochemical markers of early myocardial infarction, there
are positive findings about sorbin and SH3 domain-
containing protein 2 (SORBS2) and non-phosphorylated
connexin 43 (np-Cx43). The adapter protein SORB2 has been
proven to be an early marker with different patterns of distri-
bution in relation to the histological evidences, showing quan-
titative patterns of expression ranging from blurred loss to
total loss according to findings of contraction bands, wavy
fibres or irregular fibres [26]. About np-Cx43, the study con-
ducted on human hearts shows intense staining of the cyto-
plasm in the cases without signs of myocardial infarction,
conf i rming tha t i schaemic in jury induces non-
phosphorylation of Cx43, normally localized in intercalated
discs [28, 60, 61]. The expression of this marker in rat samples
shows very early staining (15–30 min), but a different distri-
bution pattern (nuclear) [35].
The most important evidences of the literature review
about plasma proteins concern fibronectin. The plasma
extravasation following the cardiac matrix network deg-
radation was highlighted. The protein contributes in the
formation of a fibrin-based provisional matrix that
serves as a scaffold for migration and proliferation of
infiltrating inflammatory cells, endothelial cells and fi-
broblast [62]. The usefulness of fibronectin in the foren-
sic diagnosis of early myocardial infarction is docu-
mented by experimental studies that show the overex-
pression of the antigen in various areas of the ischaemic
tissue and an increased staining in relation to the in-
crease of the interval between the coronary ligation
and death of the animals [9, 63]. The positive staining
in animal models was highlighted after 4 h from the
induced ischaemia, and similar results were obtained in
human myocardium [14, 16, 35].
The review showed that some markers were studied be-
cause the association with heart failure was highlighted.
S100A1 is abundant in cardiomyocytes and appears rapidly
in the serum after the clinical onset of myocardial ischaemia,
demonstrating the cellular depletion of the protein [64, 65].
Table 2 Summary of the results
for the main evaluated
immunohistochemical markers
Marker Staining Time after onset
Animals Human
Fibronectin Positive ≤1 h to ≥4 h Without histological signs
Troponins Loss >30 min <6 h (CT-I)
Myoglobin Loss >30 min Without histological signs
Fibrinogen Positive >30 min Without histological signs
C5b-9 Positive ≤2 h Without histological signs
C9 Positive ≥3 h <6 h
Desmin Loss ≥1 h
α-Actinin Loss ≥1 h
Vinculin Loss ≥1 h
H-FABP Loss 15 min–4 h Without histological signs
HIF-1α Positive ≈2 h
Dystrophin Loss ≥20 min
SORBS2 Loss <7 h
S100A1 Loss ≥15 min <6 h
npCX-43 Positive Without histological signs
CX-43 Loss Without histological signs
Dityrosine Positive ≥4 h
GAL-1 Positive 20 >min < 60
GAL-3 Positive ≥30 min
IL-15, MCP-1 Positive ≤4–6 h
JunB Positive ≤30 min
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Moreover, other studies show that in cardiovascular diseases,
downregulation of S100A1 contributes to the progressive con-
tractile dysfunction of the heart and increases cardiac-related
death [66, 67]. On the basis of this knowledge, the protein was
tested by an immunohistochemical study showing in an ex-
perimental animal model, in which ischaemia was induced,
the very early myocyte depletion of S100A1. Also, the deple-
tion was evaluated in human tissue without microscopic find-
ings of myocardial infarction [27]. The same clinical evi-
dences about galectin-3 were demonstrated [68–70], so this
protein was tested for the diagnosis of early myocardial infarc-
tion, demonstrating positive results as very early loss of GAL-
3 (between 30 and 60 min) from cardiomyocytes and endo-
thelial cells in an experimental animal model [32].
Some reviewed studies examine the expression of
stress- or hypoxia-induced factors expressed during is-
chaemia as a result of oxygen unavailability. These
studies concern HIF-1, a factor studied in animal
models that appears rapidly accumulated in the nuclei
after exposure to hypoxic conditions [71, 72]. The pos-
sible use of HIF-1 as an immunohistochemical marker
of early myocardial infarction is supported by evidences
of nuclear or mixed (nuclear and cytoplasmic) immuno-
staining in the myocardial tissues of subjects who died
both before and after 2 h from the onset of the symp-
toms [21]. In relation to the overexpression of HIF-1,
there is also an immunohistochemical study about prolyl
hydroxylase PHD2 and PHD3, which are involved in
the HIF-alpha chain hydroxylation on which depends
the inhibition of HIF function [73]. Comparing with
the early increase of HIF, the analysis shows the low
expressions of PHD2 and PHD3 [23].
Another hypoxia-induced protein tested is galectin-1
(GAL-1), which has been found in brain and lung hypoxic
conditions [74, 75]. The immunohistochemical study shows
GAL-1 expression in myocardial ischaemic tissue and an ear-
ly positive staining which allows defining the ischaemic area
within 24 h from the induction of ischaemia [30].
With regard to the protein products of oxidative stress,
many authors describe the reactive species produced in isch-
aemic damage. These reactive species react with the proteins,
causing the formation of amino acid radicals [76]. Knowledge
about the oxidative stress factors suggests that these could be
markers for the detection of myocardial infarction. Thus, one
of the factors studied is dityrosine, which results from the
interaction of the tyrosyl radicals with each other [77]. The
most important results highlight the intracellular distribution
of the dityrosine and positive immunostaining more docu-
mented in heart tissues from subjects with survival times of
4–24 h; also described is the dityrosine non-specificity for
myocardial infarction [29].
The last evaluated marker is JunB, a transcription
factor belonging to the activator protein 1 family, which
regulates gene expression in response to a variety of
stimuli including apoptosis [78]. The study shows very
early nuclear expression, as soon as 30 min after rats’
coronary ligation in the subendocardial region, and a
gradient of expression towards the epicardium with in-
creasing duration of ischaemia [35].
The most important results about the time and pattern of
expression of the evaluated immunohistochemical markers
are summarised in Table 2.
The reviewed studies show many limitations regarding the
influence on the usefulness of immunohistochemical markers
of some factors as autolysis or cardiopulmonary resuscitation.
Only three studies refer to performing cardiopulmonary resus-
citation and cardioversion (chemical or electrical) and merely
highlight their influence on myocardial integrity [16, 26, 29].
For this reason, the immunohistochemical evaluation can be
misrepresented, especially that related to the expression of
myocyte proteins [15, 28]. The influence of postmortem phe-
nomena is well studied on the C5b-9 complex, which results
as a reliable marker even in myocardial tissue with advanced
putrefaction and autolysis [11]. Moreover, a C9 study shows
intense and specific staining up to 10 days on the infarcted
areas after the experimental autolysis had begun [18]. There
are no other evidences related to the reliability of other
markers in cases with autolysis or putrefaction, but it is plau-
sible to consider not useful myocyte proteins in light of the
breakdown of the cells through decomposition.
In conclusion, all studies demonstrate that knowledge on
the pathophysiological mechanisms involved in the response
to myocardial infarction is a very important tool for the foren-
sic investigation of early myocardial ischaemia.
The studies reviewed allow us to consider the important
application of the immunohistochemical analysis of some bio-
markers. In fact, immunohistochemistry has been shown to
provide a substantial contribution on the issue of determining
myocardial infarct age, particularly when the routine histolog-
ical staining results are not specific. Moreover, the reviewed
studies have focused on molecules with different tissue distri-
butions that could be used in combination to demonstrate cel-
lular and extracellular damage and to study the possible dif-
ferences in the evolution of damage between these
compartments.
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